Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas
Clinical trial NCT05029960 · TERMINATED
Trial details
- NCT number
- NCT05029960
- Sponsor
- University of Rochester
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2024-05-09
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.